InvestorsHub Logo
Followers 84
Posts 1928
Boards Moderated 0
Alias Born 03/05/2014

Re: goldenisla post# 28226

Monday, 09/10/2018 1:17:47 AM

Monday, September 10, 2018 1:17:47 AM

Post# of 233066
Couldn’t agree more. You will get nada in terms of answers to your questions. I hope I am wrong but I’ve been down that road multiple times.

At this point in Pro-140’s development the word from Gilead is you got nothing. They aren’t jumping at another Combo option regardless of Pro-140’s safety profile.

Mono would be a different story. Nader knows this and is ramping to the higher dosage to hopefully grab some serious attention with 80-90% Efficacy while maintaining a strong safety profile. The question here that everyone is asking is the same one I want answered (besides financing) where are we with the 700ml dosing? Are we moving or stagnant due to lack of $? Time is $ and at this pace it’s going to be years and a different market place in terms of competition.

When Tony C quietly disappeared with the addition of Pestell the company shifted to the Cancer story with Pestell to attract new investors. That was the only way to raise money with Paulson because the HIV well was dry. Will Pestell along with Klump change the financing picture and free us from Paulson? I’m hopefully optimistic.

Personally I don’t believe anything Nader has to say until it’s fact. Especially when it comes to financing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News